Jeff Ogi Email

Director Information Technology . Cortexyme

San Francisco, CA

Location

j***@cortexyme.com

Primary Email

Current Roles

Employees:
19
Revenue:
$10.2M
About
Cortexyme is a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what we believe to be a key underlying cause of Alzheimerᅢᄁ¬ツᆲ¬トᄁs and other degenerative diseases. Cortexyme is targeting a specific pathogen found in the brain of Alzheimerᅢᄁ¬ツᆲ¬トᄁs patients that causes neurodegeneration and other pathology in animal models. Cortexymeᅢᄁ¬ツᆲ¬トᄁs lead small molecule, atuzaginstat (COR388), has advanced through Phase Ib and is currently the subject of a Phase 2/3 GAIN clinical trial in mild to moderate Alzheimerᅢᄁ¬ツᆲ¬トᄁs disease patients.
Cortexyme Address
269 East Grand Avenue
San Francisco, CA
United States
Cortexyme Email

Past Companies

Binary Technology GroupConsultant
Quince Therapeutics (formerly Cortexyme)Director of Information Technology
Law Foundation of Silicon ValleyDirector of IT

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.